Hepatic cholesterol transport from plasma into bile: Implications for gallstone disease

Current Opinion in Lipidology

Volumn 15, Issue 3, 2004, Pages 279-286

  Zanlungo, Silvana ^a   Rigotti, Attilio ^a   Nervi, Flavio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Canalicular transporters; Hepatic cholesterol; Lipoprotein receptors; Plasma lipoproteins

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; STEROL CARRIER PROTEIN 2;

BILE SECRETION; CHOLELITHIASIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CHOLESTEROL LIVER LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; GENETIC MANIPULATION; HUMAN; KNOCKOUT MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BILE; BIOLOGICAL TRANSPORT; CHOLESTEROL; GALLBLADDER; GALLSTONES; HUMANS; LIPOPROTEINS; LIVER; MICE;

EID: 2642535486     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200406000-00007     Document Type: Review

References (108)

1. Turley S, Dietschy JM. The metabolism and excretion of cholesterol by the liver. In: Arias IM, Jakoby W, Popper H, et al., editors. The liver: biology and pathobiology. New York: Raven Press; 1998. pp. 617-641.
2. Cooper AD. Hepatic uptake of chylomicron remnants. J Lipid Res 1997; 38:2173-2192.
3. Krieger M. Charting the fate of the 'good cholesterol': identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558.
4. Rigotti A, Marzolo MP, Nervi F. Lipid transport from the hepatocyte into the bile. Curr Top Membr 1994; 40:579-615.
5. Cohen DE. Hepatocellular transport and secretion of biliary lipids. Curr Opin Lipidol 1999; 10:295-302.
6. Oude Elferink RP, Groen AK. Mechanisms of biliary lipid secretion and their role in lipid homeostasis. Semin Liver Dis 2000; 20:293-305.
7. Kosters A, Jirsa M, Groen AK. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta 2003; 1637:1-19. An excellent review of cholesterol gallstone formation focused on the analysis of the pathways and candidate genes involved in biliary cholesterol secretion.
8. Horton JD, Goldstein JL, Brown MS. SR EBPs: activators of the complete program of cholesterol and salty acid synthesis in the liver. J Clin Invest 2002; 109:1125-1131.
9. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001; 294:1866-1870.
10. Miquel JF, Covarrubias C, Villarroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology 1998; 115:937-946.
11. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology 1999; 117:632-639.
12. Amigo L, Zanlungo S, Mendoza H, et al. Risk factors and pathogenesis of cholesterol gallstones: state of the art. Eur Rev Med Pharmacol Sci 1999; 3:241-246.
13. Lazcano-Ponce EC, Miquel JF, Munoz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001; 51:349-364.
14. Van Erpecum KJ, Carey MC. Apolipoprotein E4: another risk factor for cholesterol gallstone formation? Gastroenterology 1996; 111:1764-1767.
15. Gylling H, Kontula K, Miettinen TA. Cholesterol absorption and metabolism and LDL kinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. Arterioscler Thromb Vasc Biol 1995; 15:206-213.
16. Miettinen TA, Gylling H, Vanhanen H, Ollus A. Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 1992; 12:1044-1052.
17. Angelin B, Holmquist L, Leijd B, Einarsson K. Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E-2/2 phenotype. Eur J Clin Invest 1990; 20:143-149.
18. Juvonen T, Kervinen K, Kairaluoma MI, et al. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology 1993; 104:1806-1813.
19. Portincasa P, van Erpecum KJ, van De Meeberg PC, et al. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy. Hepatology 1996; 24:580-587.
20. Bertomeu A, Ros E, Zambon D, et al. Apolipoprotein E polymorphism and gallstones. Gastroenterology 1996; 111:1603-1610.
21. Fischer S, Dolu MH, Zundt B, et al. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur J Clin Invest 2001; 31:789-795.
22. Van Erpecum KJ, Van Berge-henegouwen GP, Eckhardt ER, et al. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform. Hepatology 1998; 27:1508-1816.
23. Ko CW, Beresford SA, Alderman B, et al. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology 2000; 31:18-23.
24. Mella JG, Miquel JF, Rollán A, et al. Apolipoprotein E polymorphisms in patients with cholesterol gallstones in a high risk population [Abstract]. Gastroenterology 1994; 112:A1332.
25. Amigo L, Quiñones V, Mardones P, et al. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high cholesterol diet. Gastroenterology 2000; 118:772-779.
26. Sehayek E, Shefer S, Nguyen LB, et al. Apolipoprotein E regulates dietary cholesterol absorption and biliary cholesterol excretion: studies in C57BL/6 apolipoprotein E knockout mice. Proc Natl Acad Sci U S A 2000; 97:3433-3437.
27. Bothman KM, Bravo E. The role of lipoprotein cholesterol in biliary steroid secretion: studies with in vivo experimental models. Prog Lipid Res 1995; 34:71-97
28. Thronton JR, Heaton KW, MacFarlane DG. A relation between high-density-lipoprotein cholesterol and bile saturation. BMJ 1981; 283:1352-1354.
29. Petitti DB, Friedman GD, Klatsky AL. Association of a history of gallstone disease with a reduced concentration of high density lipoprotein cholesterol. N Engl J Med 1981; 304:1396-1398.
30. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology 1990; 99:843-849.
31. Khanuja B, Cheah YC, Hunt M, et al. Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci U S A 1995; 92:7729-7733.
32. Jolley CD, Woollett LA, Turley SD, Dietschy JM. Centripetal cholesterol flux to the liver is dictated by events in the peripheral organs and not by the plasma high density lipoprotein or apolipoprotein A-I concentration. J Lipid Res 1998; 39:2143-2149.
33. Jolley CD, Dietschy JM, Turley SD. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI. Hepatology 2000; 32:1309-1316.
34. Schmitz G, Langmann T. Structure, function and regulation of the ABCA1 gene product. Curr Opin Lipidol 2001; 12:129-140.
35. Oram JF, Lawn RM. ABCA1: the gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 2001; 42:1173-1179.
36. Vaisman BL, Lambert G, Amar M, et al. ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest 2001; 108:303-309.
37. Groen AK, Bloks VW, Bandsma RH, et al. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest 2001; 108:843-850.
38. Rigotti A, Miettinen H, Krieger M. The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues. Endocr Rev 2003; 24:357-387. An extensive review of the role of SR-BI in overall lipid metabolism that includes the relevance of this lipoprotein receptor in hepatic HDL metabolism.
39. Kozarsky KF, Donahee MH, Rigotti A, et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417.
40. Sehayek E, Ono JG, Shefer S, et al. Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci U S A 1998; 95:10194-10199.
41. Ji Y, Wang N, Ramakrishnan R, et al. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 1999; 274:33398-33402.
42. Trigatti B, Rayburn H, Viñals M, et al. Influence of the HDL receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A 1999; 96:9322-9327.
43. Mardones P, Quiñones V, Amigo L, et al. Hepatic cholesterol and bile acid metabolism and intestinal cholesterol absorption in scavenger receptor class B type I (SR-BI)-deficient mice. J Lipid Res 2001; 42:170-180.
44. Wang DQ, Carey MC. Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI. Biochim Biophys Acta 2002; 1583:141-150.
45. Van Eck M, Twisk J, Hoekstra M, et al. Differential effects of scavenger receptor BI deficiency on lipid metabolism in cells of the arterial wall and in the liver. J Biol Chem 2003; 278:23699-23705.
46. Lundasen T, Liao W, Angelin B, Rudling M. Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice. J Biol Chem 2003; 278:43224-43228. This study demonstrates that leptin regulates hepatic SR-BI expression in ob/ob mice.
47. Hyogo H, Roy S, Paigen B, Cohen DE. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 2002; 277:34117-34124.
48. Wang DQ, Carey MC. Susceptibility to murine cholesterol gallstone formation is not affected by partial disruption of the HDL receptor SR-BI. Biochim Biophys Acta 2002; 1583:141-150.
49. Miquel JF, Moreno M, Amigo L, et al. Expression and regulation of scavenger receptor class B type I (SR-BI) in gallbladder epithelium. Gut 2003; 52:1017-1024. This study shows that SR-BI expression is not essential for diet-induced gallstone formation in mice (see also Ref. [48]).
50. Silver DL, Wang N, Xiao X, Tall AR. High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 2001; 276:25287-25293.
51. Sehayek E, Wang R, Ono JG, et al. Localization of the phosphatidylethanolamine methylation pathway and scavenger receptor class B type I to the canalicular membrane: evidence for apical phosphatidylcholine biosynthesis that may promote biliary excretion of phospholipid and cholesterol. J Lipid Res 2003; 44:1605-1613. In this study, the presence of SR-BI in the hepatic canalicular membrane of wildtype mice is demonstrated by immunofluorescence (however, see Refs [53,54]).
52. Ikemoto M, Arai H, Feng D, et al. Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A 2000; 97:6538-6543.
53. Stangl H, Graf GA, Yu L, et al. Effect of estrogen on scavenger receptor BI expression in the rat. J Endocrinol 2002; 175:663-666.
54. Mardones P, Pilon A, Bouly M, et al. Fibrates downregulate hepatic scavenger receptor class B type I (SR-BI) protein expression in mice. J Biol Chem 2003; 278:7884-7890.
55. Silver DL. A carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J Biol Chem 2002; 277:34042-34047.
56. Kocher O, Yesilaltay A, Cirovic C, et al. Targeted disruption of the PDZK1 gene in mice causes tissue-specific depletion of the HDL receptor SR-BI and altered lipoprotein metabolism. J Biol Chem 2003; 278:52820-52825. This study reports the relevance of the PDZK1-dependent post-transcriptional regulation of hepatic SR-BI expression on HDL cholesterol metabolism in vivo.
57. Santamarina-Fojo S, Haudenschild C, Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1998; 9:211-219.
58. Amigo L, Mardones P, Ferrada C, et al. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice. Hepatology 2003; 38:726-734. This work demonstrates that hepatic lipase deficiency has no major impact on biliary cholesterol secretion and diet-induced gallstone formation in mice.
59. Bruce C, Chouinard RA Jr, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998; 18:297-330.
60. Juvonen T, Savolainen MJ, Kairaluoma MI, et al. Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res 1995; 36:804-812.
61. Osono Y, Woollett LA, Marotti KR, et al. Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma. Proc Natl Acad Sci USA 1996; 93:4114-4119.
62. Masson D, Staels B, Gautier T, et al. Cholesteryl ester transfer protein modulates the effect of liver X receptor agonists on cholesterol transport and excretion in the mouse. J Lipid Res 2003 [Epub ahead of print 16 December 2003]. This study demonstrates that the upregulation of CETP by liver X receptor agonists stimulates biliary cholesterol secretion in CETP transgenic mice.
63. Puglielli L, Rigotti A, Amigo L, et al. Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile. Biochem J 1996; 317:681-687.
64. Zanlungo S, Amigo L, Mendoza H, et al. Overexpression of sterol carrier protein-2 leads to altered lipid metabolism and enhanced enterohepatic sterol circulation in mice. Gastroenterology 2000; 119:1708-1719.
65. Amigo L, Zanlungo S, Miquel JF, et al. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res 2003; 44:399-407. The findings of this paper indicate a key regulatory role for sterol carrier protein-2 in hepatic lipid metabolism and the existence of a reciprocal relationship between the lipid fluxes across the sinusoidal and canalicular membranes.
66. Fuchs M, Lammert F, Wang DQ-H, et al. Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice. Biochem J 1996; 336:33-37.
67. Ito T, Kawata S, Imai Y, et al. Hepatic cholesterol metabolism in patients with cholesterol gallstones: enhanced intracellular transport of cholesterol. Gastroenterology 1996; 110:1619-1627.
68. Fuchs M, Hafer A, Munch C, et al. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J Biol Chem 2001; 276:48058-48065.
69. Fielding CJ, Fielding PE. Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev 2001; 49:251-264.
70. Calvo M, Tebar F, Lopez-Iglesias C, Enrich C. Morphologic and functional characterization of caveolae in rat liver hepatocytes. Hepatology 2001; 33:1259-1269.
71. Moreno M, Molina H, Amigo L, et al. Hepatic overexpression of caveolins increases bile salt secretion in mice. Hepatology 2003; 38:1477-1488. This paper shows that hepatic caveolin overexpression in mice significantly increases bile flow and secretion of all biliary lipids, suggesting a primary effect on hepatic bile acid transport.
72. Pedraza AJ, Frank PG, Ranginani N, et al. No effect of hepatic caveolin-1 overexpression on biliary lipid secretion in C57BL/6J mice. Hepatology 2000; 32:A434 [Abstract].
73. Ioannou YA. Multidrug permeases and subcellular cholesterol transport. Nature Rev Mol Cell Biol 2001; 2:657-668.
74. Amigo L, Mendoza H, Castro J, et al. Relevance of Niemann-Pick type C1 protein expression in controlling plasma cholesterol and biliary lipid secretion in mice. Hepatology 2002; 36:819-828.
75. Soccio RE, Breslow JL. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J Biol Chem 2003; 278:22183-22186. An excellent review on the discovery and potential roles of StAR-related lipid transfer proteins in intracellular lipid transport.
76. Lehto M, Olkkonen VM. The OSBP-related proteins: a novel protein family involved in vesicle transport, cellular lipid metabolism, and cell signalling. Biochim Biophys Acta 2003; 1631:1-11. An excellent update on the expanding OSBP protein family and the evidence that connects them to cellular cholesterol and sphingomyelin metabolism and transport.
77. Stocco DM. The role of the StAR protein in steroidogenesis: challenges for the future. J Endocrinol 2000; 164:247-253.
78. Watari H, Arakane F, Moog-Lutz C, et al. MLN64 contains a domain with homology to the steroidogenic acute regulatory protein (StAR) that stimulates steroidogenesis. Proc Natl Acad Sci U S A 1997; 94: 8462-8467.
79. Alpy F, Stoeckel ME, Dierich A, et al. The StAR homolog MLN64, a late endosomal cholesterol binding protein. J Biol Chem 2000; 276:4261-4269.
80. Ridgway ND. Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochim Biophys Acta 2000; 1484:129-141.
81. Lagace TA, Byers DM, Cook HW, Ridgway ND. Altered regulation of cholesterol and cholesteryl ester synthesis in Chinese-hamster ovary cells overexpressing the oxysterol-binding protein is dependent on the pleckstrin homology domain. Biochem J 1997; 326:205-213.
82. Laitinen S, Lehto M, Lehtonen S, et al. ORP2, a homolog of oxysterol binding protein, regulates cellular cholesterol metabolism. J Lipid Res 2002; 43:245-255.
83. Wang C, Jebailey L, Ridgway ND. Oxysterol-binding-protein (OSBP)-related protein 4 binds 25-hydroxycholesterol and interacts with vimentin intermediate filaments. Biochem J 2002; 361:461-472.
84. Buhman KF, Accad M, Farese RV. Mammalian acyl-CoA:cholesterol acyltransferases. Biochim Biophys Acta 2000; 1529:142-154.
85. Chang TY, Chang CC, Lin S, et al. Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr Opin Lipidol 2001; 12:289-296.
86. Nervi F, Bronfman M, Allalon W, et al. Regulation of biliary cholesterol secretion in the rat: role of hepatic cholesterol esterification. J Clin Invest 1984; 74:2226-2237.
87. Smith JL, Hardie IR, Pillay SP, de Jersey J. Hepatic acyl-coenzyme A:cholesterol acyltransferase activity is decreased in patients with cholesterol gallstones. J Lipid Res 1990; 31:1993-2000.
88. Rigotti A, Nervi F. In search of abnormal enzyme activities of hepatic cholesterol metabolism in patients with cholesterol gallstone disease. Hepatology 1991; 14:1295-1297.
89. Buhman KK, Accad M, Novak S, Choi RS, et al. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat Med 2000; 6:1341-1347.
90. Zanlungo S, Nervi F. The ACAT2 gene encodes a gatekeeper of intestinal cholesterol absorption that regulates cholesterolemia and gallstone disease. Hepatology 2001; 33:760-761.
91. Wang R, Salem M, Yousef IM, et al. Targeted inactivation of sister of P-glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis. Proc Natl Acad Sci U S A 2001; 98:2011-2016.
92. Smit JJ, Schinkel AH, Oude Elferink RP, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993; 75:451-462.
93. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000; 290:1771-1775.
94. Lee MH, Lu K, Hazard S, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 2001; 27:79-83.
95. Bjorkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 1995. pp. 2073-2099.
96. Sudhop T, Sahin Y, Lindenthal B, et al. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion. Gut 2002; 51:860-863.
97. Yu L, York J, von Bergmann K, et al. Stimulation of cholesterol excretion by the liver X receptor agonist requires ATP-binding cassette transporters G5 and G8. J Biol Chem 2003; 278:15565-15570. See Ref. [100asterisk inside a circle sign].
98. Kosters A, Frijters RJ, Schaap FG, et al. Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice. J Hepatol 2003; 38:710-716. See Ref. [100asterisk inside a circle sign].
99. Kamisako T, Ogawa H. Regulation of biliary cholesterol secretion is associated with abcg5 and abcg8 expressions in the rats: effects of diosgenin and ethinyl estradiol. Hepatol Res 2003; 26:348-352. See Ref. [100asterisk inside a circle sign].
100. Bloks VW, Bakker-Van Waarde WM, Verkade HJ, et al. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes. Diabetologia 2004; 47:104-112. References [97asterisk inside a circle sign-100asterisk inside a circle sign] show that changes in biliary cholesterol secretion correlate with variations in hepatic ABCG5/G8 expression levels, supporting the role of these membrane transporters in controlling cholesterol flux from the liver into the bile.
101. Graf GA, Li WP, Gerard RD, et al. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 2002; 110:659-669.
102. Graf GA, Yu L, Li WP, et al. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion. J Biol Chem 2003; 278:48275-48282. This work indicates that transport of ABCG5/ABCG8 heterodimers from the endoplasmic reticulum to the canalicular membrane of hepatocytes is required for their proper function in determining biliary cholesterol secretion.
103. Yu L, Li-Hawkins J, Hammer RE, et al. Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 2002; 110:671-680.
104. Yu L, Hammer RE, Li-Hawkins J, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A 2002; 99:16237-16242.
105. Plosch T, Bloks VW, Terasawa Y, et al. Sitosterolemia in ABC-transporter G5-deficient mice is aggravated on activation of the liver-X receptor. Gastroenterology 2004; 126:290-300. This study demonstrates by disruption of the Abcg5 gene alone that functional ABCG5/G8 heterodimers are not absolutely required for biliary cholesterol secretion in mice.
106. Wittenburg H, Lyons MA, Li R, et al. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 2003; 125:868-881. This study reports a significant association between Abcg5 and Abcg8 gene loci and hepatic mRNA levels of these genes with increased biliary cholesterol secretion and gallstone weight in inbred mice with genetic susceptibility to cholelithiasis.
107. Lammert F, Carey MC, Paigen B. Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 2001; 120:221-238.
108. Carey MC, Paigen B. Epidemiology of the American Indians' burden and its likely genetic origins. Hepatology 2002; 36:781-791.